Consequently, HDAC inhibitors play inhibitory roles in cancer by reversing the EMT in many types of tumors (Fu et al., 2016; Pinkerneil et al., 2016; Zhijun et al., 2016). This evidence concerns the gene HDAC9 and cancer.